Sponsored Links


Other Topics
Sponsored Links



Quote of the Day

"At sixteen I was stupid, confused and indecisive. At twenty-five I was wise, self-confident, prepossessing and assertive. At forty-five I am stupid, confused, insecure and indecisive. Who would have supposed that maturity is only a short break in adolescence?"

Jules Feiffer

FEATURED
HEALTH
PRODUCTS
 
Guide To Healthier Eating And Weight
 
The Ultimate Collection Of Health Ebooks
 
A Healthy Back In Ten Minutes A Day
 
Complete Guide To Healthy Eating
 
Natural Health Remedies To Help Stress
 




 


Google


Warning: fopen(stopka/index.php) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117

Warning: fopen(stopka/6655d922aa2c1bbb44b556c10262be35.txt) [function.fopen]: failed to open stream: No such file or directory in /stopka.php on line 117


 
Featured Breast Cancer Articles

A Natural Remedy for Every Week of the Month
Natural ingredients, containing hidden vitamins, have been used to treat menstrual problems for hundreds of years but it is only recently that proper research has been conducted into what is, and what is not effective. In addition, when combined with ...

Braving Breast Cancer
Breast cancer is the second leading cause of cancer-related deaths. The occurrence of breast cancer continues to increase as the world progresses. This remains to be a big challenge to be faced and braved by men and women alike. What is Breast Cancer? ...

Rubber Cancer Bracelets - The Humble Tool That Raised Millions
Cancer is the second largest cause of death in America. Thousands die every year from the disease, yet no really effective cure has been found for it. Rubber cancer bracelets have contributed heavily to the cause of cancer research; millions from their ...





A Tool for Early Breast Cancer Screening
 
Who isn't familiar with the expression, "early detection is the best prevention?" We hear this term throughout the year and most everyone is familiar with this "catch phrase" as it relates to breast cancer. Obviously, a woman's chance for survival improves when a cancer is found early. We hear that simple rhyming statement but are women really offered early detection?
Our "gold standard" for breast cancer screening is mammography, clinical breast exam and self-breast exam. Other techniques are used but ALL current technologies examine structure; something is formed and large enough to be seen or felt. However, it is well-documented that a mass that is detected by mammography has been growing for 8-10 years before it was detected. Is this early detection?
There exists a technology that can detect an issue YEARS before a tumor can be seen on X-ray or palpated during an exam and truly offers early detection. This technology has been approved by the FDA as an adjunctive screening tool since 1982 and offers NO RADIATION, NO COMPRESSION AND NO PAIN. For women who are searching for early breast cancer detection, digital infrared thermal imaging (DITI) may be of interest.
Historically, DITI fell out of favor shortly after its initial debut in the early 80s. When DITI was first introduced, strict protocols and trained technicians did not exist. Shortly after its initial beginnings, DITI fell out of favor as a diagnostic tool in the medical community.
There are now very strict protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat emitted from the body and display it as a picture on a computer monitor. These images are unique to the person and remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool. Tumors or other breast diseases measures warmer than surrounding tissue and can thereby alert a physician to a problem before a tumor is actually palpable.
Medical doctors who interpret the breast scans are board certified thermologists. Thermography is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery, women who refuse mammography, or women who want clinical correlation for an already existing issue. Thermography, because it analyzes a developing process, may identify a problem several years before mammography. As we all know, early detection is important to survival.
DITI has an average sensitivity and specificity of 90%. An abnormal thermogram carries a 10x greater risk for cancer. A persistently abnormal thermogram carries a 22x greater risk for cancer. Thermography, as well as mammography is a personal choice for women. This decision ideally should be made in collaboration between you and your physician. However, thermography does not require a physician's order. Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.
About the Author
Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She has worked in the medical field for 9 years and is now an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area. To contact Brenda, email her at brenda@proactivehealthonline.com.

Breast Cancer News



ABC News

Want to lower breast cancer risk? Lose a little weight
Los Angeles Times
For postmenopausal women who are obese, breast cancer is more likely. That's because fat tissue seems to behave essentially as an organ of the endocrine system, pumping out the hormone estrogen. And estrogen is a driver of many common breast cancers.
Small weight loss effectively reduces sex hormones linked with breast cancerFox News
Moderate Weight Loss Can Decrease Breast Cancer RiskABC News
Dieting May Lower Hormone Levels Tied to Breast CancerPhiladelphia Inquirer
TIME -Times of India
all 40 news articles »

Galena Biopharma's Breast Cancer Vaccine Sprouts More Red Flags
TheStreet.com
By Adam Feuerstein 05/22/12 - 02:23 PM EDT LAKE OSWEGO, Oregon (TheStreet) -- More red flags have been found staked into Galena Biopharma's(GALE) breast cancer vaccine NeuVax. Updated, 60-month follow-up results from a Neuvax phase II study scheduled ...
Galena Biopharma With Near Term ASCO CatalystSeeking Alpha

all 2 news articles »

Plenty of options after breast cancer surgery
MiamiHerald.com
And is there anything that can be done for the other breast so that they can be similar in clothes or a bathing suit? Congratulations on being a breast cancer survivor! Breast cancer affects one in approximately eight women in America and because of ...

and more »

Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast ...
MarketWatch (press release)
BERKELEY HEIGHTS, NJ, May 22, 2012 (GLOBE NEWSWIRE) -- Genta Incorporated (GNTA) today announced results from the Company's Phase 2 clinical trial using tesetaxel as initial, single-agent chemotherapy in women with advanced breast cancer.
Advanced breast cancer drug produces positive phase 2 resultsMedCity News
Shares of Genta Inc. (GNTA) Climb as Company announces Phase II ResultsTech24

all 7 news articles »

Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO
Wall Street Journal
VX) newest breast cancer drug is expected to be displayed in the US next month at a high-profile medical meeting. Roche is planning to present additional data from key studies at the American Society of Clinical Oncology, or ASCO, annual meeting in ...

and more »